Stock listing
ASX:NUZ Neurizon Therapeutics Limited Share Price
Home listing (ASX) of Neurizon Therapeutics Limited
Follow Neurizon Therapeutics Limited into a list and get an email when it puts out news.
Share price · ASX:NUZ
$0.08 AUD -0.00 (-0.6%)
Close on Oct 20, 2026
- Day range
- $0.08 – $0.081 AUDOct 20, 2026
- Volume
- 103,873 sharesOct 20, 2026
- Market cap
- $63.33M AUDAt the close on Oct 20, 2026 · price × 791.7M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| ASX:NUZ · Home | $0.08 AUD | -0.001 (-0.6%) | 103,873 | $0.081 | $0.081 | $0.08 | $0.081 | Close on Oct 20, 2026 |
| Frankfurt:ECQ0 | €0.042 EUR | -0.001 (-1.2%) | — | €0.042 | €0.042 | €0.042 | €0.043 | Close on Oct 20, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · ASX:NUZ · AUD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.08 | -0.001 | -0.6% | $0.081 | $0.081 | $0.08 | 103,873 | |
| $0.081 | -0.001 | -1.2% | $0.083 | $0.083 | $0.081 | 248,970 | |
| $0.082 | +0.003 | +3.2% | $0.082 | $0.082 | $0.079 | 41,782 | |
| $0.079 | -0.005 | -6.0% | $0.084 | $0.084 | $0.079 | 325,131 | |
| $0.084 | -0.001 | -1.2% | $0.089 | $0.092 | $0.082 | 202,546 | |
| $0.085 | -0.004 | -4.5% | $0.091 | $0.091 | $0.085 | 769,484 | |
| $0.089 | -0.003 | -3.3% | $0.092 | $0.093 | $0.089 | 454,047 | |
| $0.092 | +0.002 | +1.7% | $0.092 | $0.093 | $0.09 | 106,437 | |
| $0.091 | +0.004 | +4.0% | $0.088 | $0.093 | $0.087 | 543,197 | |
| $0.087 | 0.00 | 0.0% | $0.089 | $0.089 | $0.086 | 97,100 | |
| $0.087 | +0.003 | +3.6% | $0.084 | $0.096 | $0.084 | 1,482,893 | |
| $0.084 | +0.004 | +5.0% | $0.082 | $0.084 | $0.082 | 206,869 | |
| $0.08 | +0.005 | +6.7% | $0.075 | $0.08 | $0.074 | 558,464 | |
| $0.075 | -0.003 | -3.8% | $0.077 | $0.077 | $0.075 | 139,929 | |
| $0.078 | +0.002 | +2.6% | $0.078 | $0.078 | $0.076 | 172,450 | |
| $0.076 | 0.00 | 0.0% | $0.077 | $0.077 | $0.076 | 108,950 | |
| $0.076 | -0.001 | -1.3% | $0.077 | $0.08 | $0.076 | 304,532 | |
| $0.077 | 0.00 | 0.0% | $0.077 | $0.079 | $0.077 | 161,162 | |
| $0.077 | -0.001 | -1.3% | $0.078 | $0.08 | $0.077 | 122,710 | |
| $0.078 | -0.001 | -1.3% | $0.079 | $0.079 | $0.078 | 53,325 | |
| $0.079 | -0.001 | -1.3% | $0.08 | $0.08 | $0.079 | 143,309 | |
| $0.08 | 0.00 | 0.0% | $0.081 | $0.081 | $0.08 | 545,000 | |
| $0.08 | 0.00 | 0.0% | $0.08 | $0.084 | $0.08 | 370,599 | |
| $0.08 | +0.001 | +1.3% | $0.078 | $0.081 | $0.078 | 469,962 | |
| $0.079 | +0.004 | +5.3% | $0.078 | $0.08 | $0.078 | 50,398 | |
| $0.075 | 0.00 | 0.0% | $0.077 | $0.077 | $0.075 | 425,203 | |
| $0.075 | -0.001 | -1.3% | $0.076 | $0.08 | $0.075 | 540,799 | |
| $0.076 | -0.002 | -2.6% | $0.076 | $0.08 | $0.073 | 338,216 | |
| $0.078 | -0.007 | -8.2% | $0.085 | $0.086 | $0.075 | 1,111,222 | |
| $0.085 | +0.023 | +37.1% | $0.063 | $0.085 | $0.063 | 3,584,337 | |
| $0.062 | -0.001 | -1.6% | $0.062 | $0.062 | $0.06 | 376,977 | |
| $0.063 | +0.007 | +12.5% | $0.057 | $0.063 | $0.055 | 729,178 | |
| $0.056 | +0.001 | +1.8% | $0.055 | $0.056 | $0.055 | 121,260 | |
| $0.055 | 0.00 | 0.0% | $0.055 | $0.055 | $0.055 | 26,305 | |
| $0.055 | 0.00 | 0.0% | $0.056 | $0.056 | $0.053 | 951,897 | |
| $0.055 | -0.001 | -1.8% | $0.056 | $0.057 | $0.055 | 909,781 | |
| $0.056 | -0.001 | -0.9% | $0.057 | $0.057 | $0.056 | 270,489 | |
| $0.057 | +0.001 | +0.9% | $0.057 | $0.057 | $0.056 | 1,066,843 | |
| $0.056 | -0.002 | -3.4% | $0.057 | $0.057 | $0.056 | 1,011,192 | |
| $0.058 | 0.00 | 0.0% | $0.058 | $0.058 | $0.057 | 137,974 | |
| $0.058 | -0.001 | -1.7% | $0.058 | $0.058 | $0.057 | 666,746 | |
| $0.059 | -0.001 | -1.7% | $0.06 | $0.06 | $0.058 | 735,210 | |
| $0.06 | +0.001 | +1.7% | $0.059 | $0.06 | $0.059 | 256,243 | |
| $0.059 | -0.001 | -1.7% | $0.06 | $0.06 | $0.058 | 772,518 | |
| $0.06 | +0.002 | +3.4% | $0.058 | $0.06 | $0.058 | 364,074 | |
| $0.058 | -0.002 | -3.3% | $0.06 | $0.061 | $0.058 | 828,838 | |
| $0.06 | -0.002 | -3.2% | $0.061 | $0.061 | $0.06 | 563,422 | |
| $0.062 | +0.001 | +1.6% | $0.061 | $0.063 | $0.06 | 590,909 | |
| $0.061 | -0.006 | -9.0% | $0.065 | $0.066 | $0.061 | 1,490,965 | |
| $0.067 | -0.002 | -2.2% | $0.069 | $0.069 | $0.066 | 736,372 | |
| $0.069 | +0.001 | +0.7% | $0.068 | $0.069 | $0.067 | 92,281 | |
| $0.068 | +0.005 | +7.9% | $0.064 | $0.068 | $0.061 | 958,752 | |
| $0.063 | 0.00 | 0.0% | $0.062 | $0.063 | $0.062 | 112,106 | |
| $0.063 | +0.001 | +1.6% | $0.063 | $0.063 | $0.062 | 138,815 | |
| $0.062 | -0.002 | -3.1% | $0.063 | $0.063 | $0.062 | 63,888 | |
| $0.064 | +0.002 | +2.4% | $0.064 | $0.064 | $0.063 | 67,266 | |
| $0.063 | +0.001 | +0.8% | $0.061 | $0.064 | $0.06 | 131,078 | |
| $0.062 | +0.003 | +4.2% | $0.059 | $0.063 | $0.057 | 577,240 | |
| $0.06 | -0.001 | -0.8% | $0.06 | $0.06 | $0.059 | 1,536,946 | |
| $0.06 | 0.00 | 0.0% | $0.06 | $0.06 | $0.06 | 643,912 | |
| $0.06 | 0.00 | 0.0% | $0.061 | $0.061 | $0.06 | 685,945 | |
| $0.06 | 0.00 | 0.0% | $0.061 | $0.061 | $0.06 | 316,486 | |
| $0.06 | -0.002 | -3.2% | $0.063 | $0.063 | $0.06 | 1,032,862 | |
| $0.062 | -0.001 | -1.6% | $0.063 | $0.066 | $0.062 | 731,546 | |
| $0.063 | -0.001 | -1.6% | $0.064 | $0.064 | $0.063 | 416,264 | |
| $0.064 | -0.001 | -1.5% | $0.066 | $0.067 | $0.063 | 803,321 | |
| $0.065 | +0.002 | +3.2% | $0.065 | $0.066 | $0.064 | 815,411 |
- Ticker
- ASX:NUZ
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- ASX
- Currency
- AUD
What changed lately
Latest news release · Oct 5, 2026
FDA Type C Feedback, HEALEY trial potentially registrational
Latest deck · Oct 7, 2026
Investor Presentation (October 2026)
Investor deck · 33 slides
Latest news
FDA Type C Feedback, HEALEY trial potentially registrational
Oct 5, 2026
Closed $0.087 (+3.6%) on Oct 6, 2026
Neurizon Announces Partial Redemption of Convertible Notes
Sep 9, 2026
Closed $0.078 (-8.2%) on Sep 10, 2026
NIH funds Expanded Access Program for NUZ-001 in ALS
Sep 8, 2026
Closed $0.085 (+37.1%) on Sep 9, 2026
Neurizon Appoints Chief Executive Officer
Sep 6, 2026
Closed $0.063 (+12.5%) on Sep 7, 2026
Appendix 4E and 2026 Annual Report
Aug 25, 2026
Closed $0.058 (-1.7%) on Aug 25, 2026
Neurizon Enters Strategic R&D Financing Facility
Jul 31, 2026
Closed $0.062 (+4.2%) on Jul 31, 2026
HEALEY ALS Platform Trial Regimen I enrolment completed - Topline results for NUZ-001 accelerated to Q2 CY2027
Jul 16, 2026
Closed $0.063 (0.0%) on Jul 17, 2026
HEALEY Enrolment Complete - Topline Accelerated to Q2 CY27
Jul 16, 2026
Closed $0.063 (0.0%) on Jul 17, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 33 slides · Oct 7, 2026
Investor Presentation (July 2026)
Investor deck · 23 slides · Jul 29, 2026
Corporate Update (May 2026)
Corporate update · 13 slides · May 28, 2026
15th Annual Australian Microcap Investment Conference 2026
Conference · 27 slides · May 11, 2026
Neurizon Therapeutics Limited on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 31 in the last 12 months · 364 in all · newest Oct 5, 2026 · oldest 2016
- Decks
- 16 decks · latest Oct 7, 2026
Where Neurizon Therapeutics Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| ASX:NUZ · Home listing · This page | ASX | Australia | AUD |
| LS Exchange:A40STF | LS Exchange | Germany | EUR |
| Lang & Schwarz:A40STF | Lang & Schwarz | Germany | EUR |
| LS Exchange:A0DNJ3 | LS Exchange | Germany | EUR |
| Frankfurt:ECQ0 | Frankfurt | Germany | EUR |
| Lang & Schwarz:A0DNJ3 | Lang & Schwarz | Germany | EUR |
| OTC:NUZTF | OTC | United States | USD |
| Stuttgart:ECQ0 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Neurizon Therapeutics Limited.